Health and Fitness Health and Fitness
Thu, November 11, 2010
[ Thu, Nov 11th 2010 ] - Market Wire
Health Management Associates, Inc. to Present at .. 0 Bank of America Merrill Lynch Credit Conference
Wed, November 10, 2010
[ Wed, Nov 10th 2010 ] - Market Wire
Alliance Oncology Appoints John J. Kresl, M.D., Ph.D., to Chief Medical Officer
[ Wed, Nov 10th 2010 ] - Market Wire
Incytea?s Selective Oral JAK1 and JAK2 Inhibitor .. Ia Results in Patients with Active Rheumatoid Art
[ Wed, Nov 10th 2010 ] - Market Wire
SuperGen Discontinues Clinical Development of SGI-1776
[ Wed, Nov 10th 2010 ] - Market Wire
NUVO RESEARCH U.S. AWARDED US$1.3 MILLION IN RESEARCH GRANTS
[ Wed, Nov 10th 2010 ] - Market Wire
Bioject Reports Third Quarter 2010 Financial Results
[ Wed, Nov 10th 2010 ] - Market Wire
CORRECTING and REPLACING Health Net Earns Strong Regional Quality Rankings
[ Wed, Nov 10th 2010 ] - Market Wire
Micromet Announces the Sale of Common Stock
[ Wed, Nov 10th 2010 ] - Market Wire
St. Jude Medical and AGA Medical Announce Early Termination of HSR Waiting Period
[ Wed, Nov 10th 2010 ] - Market Wire
Biogen Idec to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
[ Wed, Nov 10th 2010 ] - Market Wire
DexCom to Present at Upcoming Investor Conferences
[ Wed, Nov 10th 2010 ] - Market Wire
Covidien to Present at Lazard Healthcare Conference
[ Wed, Nov 10th 2010 ] - Market Wire
Alkermesa? Corporate Presentation to be Webcast a .. the Lazard Capital Markets Healthcare Conference
[ Wed, Nov 10th 2010 ] - Market Wire
ArQule, Inc. to Present at Lazard Capital Markets 7th Annual Healthcare Conference
[ Wed, Nov 10th 2010 ] - Market Wire
Alnylam Presents Additional Interim Phase I Data .. NAi Therapeutic for the Treatment of Liver Cancer
[ Wed, Nov 10th 2010 ] - Market Wire
ImmunoGen, Inc. Announces Webcast of Presentation .. Capital Markets 7th Annual Healthcare Conference
[ Wed, Nov 10th 2010 ] - Market Wire
Abiomed to Present at Lazard Capital Markets 7th Annual Healthcare Conference
[ Wed, Nov 10th 2010 ] - Market Wire
Exelixis Announces Webcasts of Investor Events in November and December
[ Wed, Nov 10th 2010 ] - Market Wire
Enzo Biochem to Present at Lazard Capital Markets 7th Annual Healthcare Conference
[ Wed, Nov 10th 2010 ] - Market Wire
MannKind to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
[ Wed, Nov 10th 2010 ] - Market Wire
Apricus Biosciences Announces 2010 Third Quarter Financial Results Conference Call
[ Wed, Nov 10th 2010 ] - Market Wire
Dendreon, Ambac Financial Group, Ultra Petroleum, Marsh & McLennan Companies and U.S. Cellular
[ Wed, Nov 10th 2010 ] - Market Wire
Celgene, Skechers USA, Dean Foods, Priceline.com and JA Solar Holdings
[ Wed, Nov 10th 2010 ] - Market Wire
Medisafe 1 Technologies to Exhibit at World's Largest Medical Conference
[ Wed, Nov 10th 2010 ] - Market Wire
RXi Pharmaceuticals to Webcast Presentation at th .. zard Capital Markets Annual Healthcare Conference
[ Wed, Nov 10th 2010 ] - Market Wire
American Bio Medica Corporation Third Quarter 2010 Conference Call and Webcast
[ Wed, Nov 10th 2010 ] - Market Wire
Neoprobe Announces Third Quarter 2010 Results
[ Wed, Nov 10th 2010 ] - Market Wire
CytRx Initiates Pharmacokinetic Clinical Trial with Bafetinib in Brain Cancer
[ Wed, Nov 10th 2010 ] - Market Wire
Health Net Earns Strong Regional Quality Rankings
[ Wed, Nov 10th 2010 ] - Market Wire
Fibrocell Science, Inc. to Present at the Maxim Group Growth Conference

Fibrocell Science, Inc. to Present at the Maxim Group Growth Conference


Published on 2010-11-10 05:16:44 - Market Wire
  Print publication without navigation


EXTON, Pa.--([ BUSINESS WIRE ])--Fibrocell Science, Inc. (OTCBB: FCSC), a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that David M. Pernock, the Companya™s Chairman and CEO, will be presenting at the Maxim Group Growth Conference to be held on Thursday, November 18, 2010, at The Grand Hyatt Hotel in New York.

Fibrocella™s presentation is scheduled for 3:30 p.m. Eastern Time.

The audio portion of the presentation will be webcast live, and a replay will be available on the Investors section of the Company's website at [ www.fibrocellscience.com ].

About Fibrocell Science, Inc.

Fibrocell Science, Inc. (OTCBB: FCSC) is a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications. Fibrocell Science is committed to advancing the scientific, medical and commercial potential of autologous skin and tissue, as well its innovative cellular processing technology and manufacturing excellence. For additional information, please visit [ www.fibrocellscience.com ].

Contributing Sources